Search Results - "Martinez-Roca, A"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    This result is not displayed to guests.

    Save to List
  2. 2

    This result is not displayed to guests.

    Save to List
  3. 3

    A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition.

    Authors: Jiménez-Vicente, Carlos Garrote, Marta López-Guerra, Mónica et al.

    Source: Leukemia & Lymphoma. Mar2024, Vol. 65 Issue 3, p394-398. 5p.

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.

    Authors: Jiménez‐Vicente, Carlos Charry, Paola Castaño‐Diez, Sandra et al.

    Source: British Journal of Haematology. Jul2024, Vol. 205 Issue 1, p256-267. 12p.

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    LBA: Colonoscopy Intervals and Colorectal Cancer in Patients with Polyps.

    Authors: Jover, R Bretthauer, M Cubiella, J et al.

    Source: Endoscopy. 2026, Vol. 58 Issue 12, pS11-S12. 2p.

    Save to List
  6. 6

    International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data.

    Authors: Turki AT Fan Y Hernández-Sánchez A et al.

    Source: Nature communications [Nat Commun] 2026 Mar 20; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 20.

    Publication Type: Journal Article

    Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  7. 7

    Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

    Authors: Jimenez-Vicente C Cardus A Castaño-Diez S et al.

    Corporate Authors: Jimenez-Vicente C Cardus A Castaño-Diez S et al.

    Source: Blood cancer journal [Blood Cancer J] 2025 May 14; Vol. 15 (1), pp. 94. Date of Electronic Publication: 2025 May 14.

    Publication Type: Letter

    Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

    HTML Full Text PDF Full Text
    Save to List
  8. 8

    Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.

    Authors: Jiménez-Vicente C Arribas I Pomares H et al.

    Source: Haematologica [Haematologica] 2025 Jun 01; Vol. 110 (6), pp. 1402-1406. Date of Electronic Publication: 2025 Jan 23.

    Publication Type: Journal Article

    Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process

    Save to List
  9. 9

    Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.

    Authors: Jimenez-Chillon C Othman J Taussig D et al.

    Source: Blood advances [Blood Adv] 2024 Jan 23; Vol. 8 (2), pp. 343-352.

    Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

    Save to List

Search Tools: